CN Patent

CN105142631A — 抗癌药物和用途

Assigned to Biocopea Ltd · Expires 2015-12-09 · 10y expired

What this patent protects

一种包括癌症治疗剂药物组合物，该癌症治疗剂能够抑制和/或降低癌细胞吸收和利用葡萄糖或其他能源、脂质或者细胞膜或细胞器的其他基本成分和/或胆固醇的能力。该药物组合物可以包括一种或多种能够单独施用或组合施用至个体的癌症治疗剂。

USPTO Abstract

一种包括癌症治疗剂药物组合物，该癌症治疗剂能够抑制和/或降低癌细胞吸收和利用葡萄糖或其他能源、脂质或者细胞膜或细胞器的其他基本成分和/或胆固醇的能力。该药物组合物可以包括一种或多种能够单独施用或组合施用至个体的癌症治疗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN105142631A
Jurisdiction
CN
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Biocopea Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.